C9 and amyotrophic lateral sclerosis: After stringent quality control, we performed an EWAS of C9orf72 (C9) repeat expansion status (wild-type or expanded) within 1748 ALS patients (see Supplementary Tables S1–3 for an overview of QC steps and study population).